THE COMPLICATIONS OF CIRRHOSIS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS HAVE DIABETES MELLITUS

Thanh Nam Nguyễn1,, Văn Chương Hoàng1, Văn Khanh Nguyễn1,2, Công Long Nguyễn1,2
1 Gastroenterology - Hepatobiliary Center, Bach Mai Hospital
2 University of Medicine and Pharmacy - Hanoi National University

Main Article Content

Abstract

Background: The prevalence of diabetes mellitus in patients with cirrhosis ranges from 14−71 %. Diabetes mellitus is associated with an increased risk of hepatic complications and death in patients with liver cirrhosis. Objectives: To investigate the complications of cirrhosis in patients with decompensated cirrhosis have diabetes mellitus. Method: Descriptive cross-sectional study was carried out at Bach Mai hospital between August 2021 and Octocber 2022, in which 200 patients with decompenstated cirrhosis were recruited. Results: In all, 72 patients had diabetes mellitus (36%).  In the group with diabetes mellitus, the most common complication of decompenstated cirrhosis is ascites  (61.6%). Patients with diabetes mellitus had a significantly higher prevalence (29.2% vs 10.2%; P = 0.03) of hepatic encephalopathy than patients without diabetes mellitus. However, there were no significant differences between the two groups in the prevalence of ascites, Spontaneous bacterial peritonitis, hepatorenal syndrome and variceal hemorrhage. Patients with diabetes mellitus had higher prevalence (27.8% vs 15.6%; P = 0.039)  of infection than those without diabetes mellitus. Conclusion: the prevalence of diabetes in decompenstated cirrhosis is 36%. Diabetes mellitus is associated with a higher prevalence of hepatic encephalopathy in patients with decompenstated cirrhosis.

Article Details

References

1. Angeli P, Bernardi M, Villanueva C, et al. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406-460. doi:10.1016/j.jhep.2018.03.024
2. Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, Maldonado-Garza H. Liver cirrhosis and diabetes: Risk factors, pathophysiology, clinical implications and management. World J Gastroenterol WJG. 2009;15(3):280. doi:10.3748/wjg.15.280
3. Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease | Diabetes Care | American Diabetes Association. Accessed December 1, 2022. https://diabetesjournals.org/care/article/30/3/734/25518/Spectrum-of-Liver-Disease-in-Type-2-Diabetes-and
4. García-Compeán D, González-González JA, Lavalle-González FJ, González-Moreno EI, Maldonado-Garza HJ, Villarreal-Pérez JZ. The treatment of diabetes mellitus of patients with chronic liver disease. Ann Hepatol. 2015;14(6):780-788. doi:10.5604/16652681.1171746
5. Goh GBB, Pan A, Chow WC, Yuan JM, Koh WP. Association between diabetes mellitus and cirrhosis mortality: the Singapore Chinese Health Study. Liver Int Off J Int Assoc Study Liver. 2017;37(2):251-258. doi:10.1111/liv.13241
6. Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, Maldonado-Garza H. Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol. 2009;15(3):280-288. doi:10.3748/wjg.15.280
7. Tripathi D, Stanley AJ, Hayes PC, et al. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut. 2015;64(11):1680-1704. doi:10.1136/gutjnl-2015-309262
8. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3):397-417. doi:10.1016/j.jhep.2010.05.004
9. Surviving Sepsis Campaign Guidelines 2021 | SCCM. Accessed December 1, 2022. https:// www.sccm.org/Clinical-Resources/Guidelines/ Guidelines/Surviving-Sepsis-Guidelines-2021